The purpose of this study is to evaluate the effects of different atypical antipsychotics on weight changes, energy homeostasis, metabolism, energy intake as well as activity. Patients with schizophrenia or schizoaffective disorders will be randomly assigned to be treated with ziprasidone or olanzapine for 24 weeks. Primary outcome parameter are the weight changes after 24 weeks.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
40
treatment with either Olanzapine or Ziprasidone
treatment with either Olanzapine or Ziprasidone
Charité Universitaetsmedizin Berlin; Campus Charité Mitte; Dept. for Psychiatry and Psychotherapy
Berlin, Germany
Primary outcome parameter are the weight changes after 24 weeks between olanzapine and ziprasidone treatment
Time frame: during treatment
Changes in energy homeostasis, food intake, metabolism
Time frame: during and after treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.